This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ajou University Industry-Academic Cooperation Foundation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Haseeb Muhammad: Innovator in Therapeutic Compounds
Introduction
Haseeb Muhammad is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific signaling pathways in the immune system.
Latest Patents
Haseeb Muhammad holds a patent for a small molecule compound that inhibits the signal transmission path of TLR7 and TLR9. This compound, described in his patent, is a chemical formula that can be utilized as a therapeutic agent for various autoimmune diseases. The compound effectively blocks TNF-α secretion by inhibiting the expression and activation of NF-κB- and MAPK-related proinflammatory genes. This innovative approach has potential applications in treating conditions such as systemic lupus erythematosus, psoriasis, and psoriatic arthritis.
Career Highlights
Haseeb is affiliated with the Ajou University Industry-Academic Cooperation Foundation, where he engages in research and development of novel therapeutic agents. His work is characterized by a strong focus on addressing autoimmune diseases through innovative chemical solutions.
Collaborations
Haseeb collaborates with esteemed colleagues, including Sangdun Choi and Yang-Seon Choi, who contribute to his research endeavors and enhance the impact of his work in the field.
Conclusion
Haseeb Muhammad's contributions to the development of therapeutic compounds demonstrate his commitment to advancing medical science. His innovative patent reflects a significant step forward in the treatment of autoimmune diseases, showcasing the potential of targeted therapies in improving patient outcomes.